Detalhe da pesquisa
1.
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.
Gynecol Oncol
; 184: 168-177, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325276
2.
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design.
Int J Gynecol Cancer
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627035
3.
Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers.
Int J Cancer
; 152(4): 781-793, 2023 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214786
4.
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Cancer
; 129(12): 1846-1855, 2023 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37060236
5.
Outcomes associated with treatment to all sites of disease in patients with stage IVB cancer of the cervix.
Int J Gynecol Cancer
; 33(5): 683-691, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36963801
6.
Real-life data on treatment and outcomes in advanced ovarian cancer: An observational, multinational cohort study (RESPONSE trial).
Cancer
; 128(16): 3080-3089, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714310
7.
Niraparib treatment for patients with BRCA-mutated ovarian cancer: review of clinical data and therapeutic context.
Future Oncol
; 18(23): 2505-2536, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35791804
8.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 22(5): 620-631, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743851
9.
Frequency and prediction of deep uterine involvement in advanced high-grade epithelial ovarian cancer: is uterine preservation an option?
Int J Gynecol Cancer
; 31(2): 251-256, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33172922
10.
Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.
Mol Cell Proteomics
; 18(5): 865-875, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30760538
11.
Evaluation of surgical resection in advanced ovarian, fallopian tube, and primary peritoneal cancer: laparoscopic assessment. A European Network of Gynaecological Oncology Trial (ENGOT) group survey.
Int J Gynecol Cancer
; 30(6): 819-824, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32354792
12.
Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers.
Cancer
; 125(5): 698-703, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30489631
13.
Outcome according to residual disease (surgeon's report vs pre-chemotherapy imaging) in patients with bevacizumab-treated ovarian cancer: Analysis of the ROSiA study.
J Surg Oncol
; 120(4): 786-793, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31368160
14.
Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study.
Int J Gynecol Cancer
; 29(1): 133-139, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30640695
15.
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial.
Lancet Oncol
; 19(8): 1126-1134, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30026002
16.
Safety and Efficacy of Extended Bevacizumab Therapy in Elderly (≥70 Years) Versus Younger Patients Treated for Newly Diagnosed Ovarian Cancer in the International ROSiA Study.
Int J Gynecol Cancer
; 28(4): 729-737, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29498983
17.
Gynecological Lymphoma: A Case Series and Review of the Literature.
J Comput Assist Tomogr
; 42(3): 435-440, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29369946
18.
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol
; 18(9): 1274-1284, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28754483
19.
Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study.
Int J Gynecol Cancer
; 27(1): 50-58, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27749456
20.
Fertility preservation in women with borderline ovarian tumors - how does it impact disease outcome? A cohort study.
Acta Obstet Gynecol Scand
; 96(11): 1300-1306, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28815550